 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KR Choksey is bullish on Supriya Lifesciences has recommended buy rating on the stock with a target price of Rs 292 in its research report dated May 31, 2023.

Buy Supriya Lifesciences; target of Rs 292: KR Choksey

Supriya Lifesci Standalone March 2023 Net Sales at Rs 142.27 crore, down 21.51% Y-o-Y

KR Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 278 in its research report dated February 17, 2023.

Buy Supriya Lifescience; target of Rs 278: KR Choksey

Supriya Lifesci Standalone September 2022 Net Sales at Rs 112.17 crore, down 24.21% Y-o-Y

The Board simultaneously approved the appointment of Rajeev Kumar Jain as Chief Executive Officer and Key Managerial Personnel of the Company, who will be joining on October 3, 2022.

Supriya Lifescience stock tumbles as CEO resigns

KR Choksey recommended accumulate rating on Supriya Lifescience with a target price of Rs 410 in its research report dated August 18, 2022.

Accumulate Supriya Lifescience; target of Rs 410: KR Choksey

KR Choksey is bullish on Supriya Lifescience has recommended buy rating on the stock with a target price of Rs 410 in its research report dated July 02, 2022.

Buy Supriya Lifescience; target of Rs 410: KR Choksey

Supriya Lifescience Ltd. supplies active pharmaceuticals ingredients (“APIs”), with a focus on research and development. Its products include 39 APIs focused diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. The company was founded by Satish Waman Wagh on March 26, 2008 and is headquartered in Mumbai, India.

Watchers	34
52-Wk Low	170.15
52-Wk High	313.20

Market Cap	22.45B
Volume (M)	182,143.00
52-Wk High	313.20
52-Wk Low	170.15

SUPRIYA.NSE Supriya Lifescience Ltd.

About

Feed

News

Fundamentals